These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32562245)

  • 41. Psychological insulin resistance among type 2 diabetic patients attending primary healthcare centers, Al-Ahsa, Saudi Arabia.
    Alomran AM; Almubarak DA; Alrashed BA; Khan AS
    J Family Community Med; 2020; 27(3):192-199. PubMed ID: 33354150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A survey of blood glucose monitoring in patients with type 2 diabetes: are recommendations from health care professionals being followed?
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():31-7. PubMed ID: 22106976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study.
    Odawara M; Ishii H; Tajima N; Iwamoto Y
    Curr Med Res Opin; 2016; 32(4):681-6. PubMed ID: 26743676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
    Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S
    Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
    Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
    Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.
    Roborel de Climens A; Pain E; Boss A; Shaunik A
    Diabetes Ther; 2020 Aug; 11(8):1873-1881. PubMed ID: 32533547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus.
    Alidrisi HA; Bohan A; Mansour AA
    Cureus; 2021 Sep; 13(9):e18263. PubMed ID: 34712538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia.
    Carter J; Roberts A
    Curr Med Res Opin; 2008 Oct; 24(10):2741-9. PubMed ID: 18715525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes App-Related Text Messages From Health Care Professionals in Conjunction With a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial.
    Grady M; Katz LB; Cameron H; Levy BL
    JMIR Diabetes; 2017 Aug; 2(2):e19. PubMed ID: 30291092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prioritising target behaviours for research in diabetes: Using the nominal group technique to achieve consensus from key stakeholders.
    Mc Sharry J; Fredrix M; Hynes L; Byrne M
    Res Involv Engagem; 2016; 2():14. PubMed ID: 29062515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study.
    Idris I; Peng X; He X; Liu D; Balogh E; Kaushik P; Van Brunt K
    Diabetes Ther; 2018 Dec; 9(6):2245-2257. PubMed ID: 30269224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Barriers of the initiation of insulin treatment in type 2 diabetic patients - conquering the "psychological insulin resistance"].
    Rácz O; Linková M; Jakubowski K; Link R; Kuzmová D
    Orv Hetil; 2019 Jan; 160(3):93-97. PubMed ID: 30640530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peer Education Group Intervention to Reduce Psychological Insulin Resistance: A Pilot Mixed-Method Study in a Chinese Population.
    Or KY; Yip BH; Lau CH; Chen HH; Chan YW; Lee KP
    Diabetes Ther; 2018 Feb; 9(1):113-124. PubMed ID: 29218568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers and enablers to the delivery of psychological care in the management of patients with type 2 diabetes mellitus in China: a qualitative study using the theoretical domains framework.
    Chapman A; Yang H; Thomas SA; Searle K; Browning C
    BMC Health Serv Res; 2016 Mar; 16():106. PubMed ID: 27025727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
    ; Rieckmann P; Centonze D; Elovaara I; Giovannoni G; Havrdová E; Kesselring J; Kobelt G; Langdon D; Morrow SA; Oreja-Guevara C; Schippling S; Thalheim C; Thompson H; Vermersch P; Aston K; Bauer B; Demory C; Giambastiani MP; Hlavacova J; Nouvet-Gire J; Pepper G; Pontaga M; Rogan E; Rogalski C; van Galen P; Ben-Amor AF
    Mult Scler Relat Disord; 2018 Jan; 19():153-160. PubMed ID: 29241142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals.
    Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I
    Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and determinants of psychological insulin resistance among type 2 diabetic patients in Kinshasa, Democratic Republic of Congo.
    Rita SL; Lubaki FJ; Bompeka LF; Ogunbanjo GA; Ngwala LP
    Afr J Prim Health Care Fam Med; 2019 Jul; 11(1):e1-e5. PubMed ID: 31368319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Group visits to encourage insulin initiation: targeting patient barriers.
    Kuo CR; Quan J; Kim S; Tang AH; Heuerman DP; Murphy EJ
    J Clin Nurs; 2017 Jun; 26(11-12):1705-1713. PubMed ID: 27602873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.